Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Abstract Text:

S Nakade,J Komaba,T Ohno,J Kitagawa,K Furukawa,Y Miyata,S Nakade,J Komaba,T Ohno,J Kitagawa,K Furukawa,Y Miyata,

Objective: A study was conducted to assess the bioequivalence of two limaprost alfadex 5 Amicrog tablets, a moisture-resistant tablet (dextran formulation) and a standard tablet (lactose formulation). Materials and methods: The clinical investigation was designed as a randomized, open-labeled, two-part, two-treatment, two-period crossover study, in 120 healthy male volunteers. One tablet of either formulation was administered with 200 ml of water after 10-hour overnight fast. After dosing, serial blood samples were collected for a period of 6 hours. Plasma harvested from blood was analyzed for limaprost by a validated LC/MS/MS method. The peak plasma concentration (Cmax) values and time associated with the maximal concentration (tmax) were obtained from the observed data. The elimination rate constant (lambda z) was obtained as the slope of the linear regression of the log-transformed concentration values vs. time data in the terminal phase, and the elimination half-life (t1/2) was calculated as 0.693/lambda z. The area under the curve to the last measurable point (AUC0-t) was estimated by the linear trapezoidal rule. The analysis of variance (ANOVA) was carried out using log-transformed AUC0-t, AUC0-A yen and Cmax and untransformed tmax, and 90% confidence intervals for AUC0-t and Cmax were calculated. If the 90% confidence intervals (CI) for both AUC0-t and Cmax fell fully within the interval 80 â 125%, the bioequivalence of the two formulations was established. Results: The means of AUC0-t were 0.779 vs. 0.754 pg A h/ml (test vs. reference), and the means of the Cmax were 1.26 vs. 1.12 pg/ml (test vs. reference). The geometric mean ratios of the test formulation to reference formulation for AUC0-t and Cmax were 104.0 and 112.4%, respectively, and the 90% CI for AUC0-t and Cmax were 100.7 â 107.4% and 105.6 â 119.6%, respectively. Both 90% CI for AUC0-t and Cmax fell within the Ministry of Health, Labour and Welfare of Japan accepted bioequivalence range of 80 â 125%. Conclusions: Based on the results, the moisture-resistant tablet was determined to be bioequivalent to the standard tablet.

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Publishing Authors By Initials

S Nakade,J Komaba,T Ohno,J Kitagawa,K Furukawa,Y Miyata,S Nakade,J Komaba,T Ohno,J Kitagawa,K Furukawa,Y Miyata,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Journal Published:

PUBLICATION TYPE: Journal Article

Journal: International journal of clinical pharmacology and

VOLUME: 46

Page Numbers: 42-7

Journal Abbreviation:

ISSN: 0946-1965

DAY: 25

MONTH: Jan

YEAR: 2008

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9423309

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation). Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).

AFFILIATION: 1Pharmacokinetic Research Laboratories, Ono Pharmaceutical Co., Ltd., Ibaraki, and 2Project Coordination & Data Management, Ono Pharmaceutical Co., Ltd., Osaka, Japan.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Clin Pharmacol Ther

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bioequivalence study of two limaprost alfadex 5 Amicrog tablets in healthy subjects: moisture-resistant tablet dextran formulation versus standard tablet lactose formulation Related Publications

• A large deletion of the PROS1 gene in a deep vein thrombosis patient with protein S deficiency.
• A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.
• A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia.
• Analysis of the p450 aromatase gene expression in the Xenopus brain and gonad.
• Bone regeneration by recombinant human bone morphogenetic protein-2 and a novel biodegradable carrier in a rabbit ulnar defect model.
• Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others.
• Cytoskeletal "jellyfish" structure of Mycoplasma mobile.
• Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors.
• Dexamethasone suppresses mucus production and MUC-2 and MUC-5AC gene expression by NCI-H292 cells.
• Distinct properties of corticothalamic and primary sensory synapses to thalamic neurons.
• Editorial.
• Establishment of a sandwich ELISA for human megsin, a kidney-specific serine protease inhibitor.
• Identification of a cross-linked peptide of a covalent complex between adrenodoxin reductase and adrenodoxin.
• Insecticide susceptibility of surviving Cotesia plutellae (Hym: Braconidae) and Diaeretiella rapae (M'Intosh) (Hym: Aphidiidae) as affected by sublethal insecticide dosages on host insects.
• Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model.
• Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells.
• Measurement of advanced glycation endproducts in skin of patients with rheumatoid arthritis, osteoarthritis, and dialysis-related spondyloarthropathy using non-invasive methods.
• New series of antiprion compounds: pyrazolone derivatives have the potent activity of inhibiting protease-resistant prion protein accumulation.
• Outbreak of CTX-M-3-type extended-spectrum beta-lactamase-producing Enterobacter cloacae in a pediatric ward.
• Preliminary X-ray studies on Serratia protease.
• Protein tyrosine kinase 2beta as a candidate gene for hypertension.
• Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
• Studies on denitrification. XIV. The electron donating system in the reduction of nitric oxide and nitrate.
• Survey of the morphogenetic dynamics of the ventricular surface of the developing mouse neocortex.
• Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model.
• The NH2-terminal structures of human and rat liver microsomal NADH-cytochrome b5 reductases.
• Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model.
• [A case of pancreatic endocrine tumor associated with Cushing's syndrome]
• [Atrioventricular dissociation]
• [Molecular mechanism of Mycoplasma gliding; a unique biomotility]